Combinatorial flexibility of cytokine function during human T helper cell differentiation
暂无分享,去创建一个
Nicolas Servant | Maximilien Grandclaudon | Vassili Soumelis | Takeshi Satoh | N. Servant | V. Soumelis | N. Manel | A. Cappuccio | T. Satoh | Nicolas Manel | Antonio Cappuccio | Maxime Touzot | Carolina Martinez-Cingolani | Carolina Martínez-Cingolani | M. Touzot | M. Grandclaudon | Maximilien Grandclaudon
[1] B. Beutler,et al. TYPE I INTERFERONS (/) IN IMMUNITY AND AUTOIMMUNITY , 2005 .
[2] J. Routy,et al. Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T Cells Are Highly Permissive to HIV-1 Infection , 2009, The Journal of Immunology.
[3] F. Belardelli,et al. Interferon-α and cancer : Mechanisms of action and new perspectives of clinical use , 2007 .
[4] Emmanuel Barillot,et al. EMA - A R package for Easy Microarray data analysis , 2010, BMC Research Notes.
[5] M. Hattori,et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.
[6] F. Belardelli,et al. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. , 2007, Biochimie.
[7] Christine A. Biron,et al. Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente , 2006, Science.
[8] B. Becher,et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. , 2008, Immunity.
[9] M. Biffi,et al. References Subscriptions Permissions Email Alerts The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I , 2013 .
[10] S. Pestka,et al. Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. , 2005, Pharmacology & therapeutics.
[11] L. Rönnblom,et al. The interferon signature in autoimmune diseases , 2013, Current opinion in rheumatology.
[12] G. Trinchieri,et al. Type I interferon: friend or foe? , 2010, The Journal of experimental medicine.
[13] D. Douek,et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.
[14] A. Iwasaki,et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection , 2011, Proceedings of the National Academy of Sciences.
[15] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[16] Y. Mitsui,et al. Elucidation of the basic three-dimensional structure of type I interferons and its functional and evolutionary implications. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[17] D. Littman,et al. Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.
[18] Jelena S. Bezbradica,et al. Integration of cytokine and heterologous receptor signaling pathways , 2009, Nature Immunology.
[19] A. Chervonsky,et al. Successful Transmission of a Retrovirus Depends on the Commensal Microbiota , 2011, Science.
[20] Andrea J Pruijssers,et al. Intestinal Microbiota Promote Enteric Virus Replication and Systemic Pathogenesis , 2011, Science.
[21] E. Barillot,et al. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses , 2008, Nature Immunology.
[22] J. Farrar,et al. Cutting Edge: Type I IFN Reverses Human Th2 Commitment and Stability by Suppressing GATA3 , 2010, The Journal of Immunology.
[23] T. Decker,et al. The Yin and Yang of type I interferon activity in bacterial infection , 2005, Nature Reviews Immunology.
[24] Michael N. Alonso,et al. Regulation of human Th9 differentiation by type I interferons and IL‐21 , 2010, Immunology and cell biology.
[25] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[26] E. Wherry,et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. , 2012, Immunity.
[27] Dan R. Littman,et al. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.
[28] R. Vance,et al. Induction of type I interferons by bacteria , 2010, Cellular microbiology.
[29] H. Tilg,et al. Interferon-alpha controls IL-17 expression in vitro and in vivo. , 2008, Immunobiology.
[30] V. Pascual,et al. A genomic approach to human autoimmune diseases. , 2010, Annual review of immunology.
[31] Graham R. Foster,et al. Interferons at age 50: past, current and future impact on biomedicine , 2007, Nature Reviews Drug Discovery.
[32] J. Feld,et al. Hepatitis C virus infection , 2015, Canadian Medical Association Journal.
[33] A. Bertoletti,et al. Type I IFN Negatively Regulates CD8+ T Cell Responses through IL-10-Producing CD4+ T Regulatory 1 Cells1 , 2005, The Journal of Immunology.
[34] Charles M. Rice,et al. Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response , 2015, Nature.
[35] Lawrence Steinman,et al. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis , 2010, Nature Medicine.
[36] Virginia Pascual,et al. An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.
[37] B. Beutler,et al. Type I interferons (alpha/beta) in immunity and autoimmunity. , 2005, Annual review of immunology.
[38] D. Levy,et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells , 2010, Nature.
[39] J. Bluestone,et al. Control of TH17 cells occurs in the Small Intestine , 2011, Nature.